Relationship between γ-glutamyltransferase and metabolic syndrome in a Korean population

被引:28
作者
Lee, M. Y. [1 ]
Koh, S. B. [3 ,4 ]
Koh, J. H. [1 ]
Nam, S. M. [1 ]
Shin, J. Y. [1 ]
Shin, Y. G. [1 ]
Kong, I. D. [2 ,5 ]
Ryu, S. Y. [6 ]
Lee, T. Y. [7 ]
Park, J. K. [3 ,4 ]
Chung, C. H. [1 ,2 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea
[2] Yonsei Univ, Wonju Coll Med, Inst Lifelong Hlth, Wonju, South Korea
[3] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea
[4] Yonsei Univ, Wonju Coll Med, Inst Occupat Med, Wonju, South Korea
[5] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea
[6] Chosun Univ, Coll Med, Dept Prevent Med, Kwangju, South Korea
[7] Chungnam Natl Univ, Coll Med, Dept Prevent Med, Taejon, South Korea
关键词
gamma-glutamyltransferase; metabolic syndrome; oxidative stress; insulin resistance; inflammation;
D O I
10.1111/j.1464-5491.2008.02415.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate associations between gamma-glutamyltransferase (GGT) and components of metabolic syndrome (MS), insulin resistance and inflammatory markers in the Korean population. Methods The 3508 subjects enrolled in this survey participated in the Korean Rural Genomic Cohort (KRGC) study. Written consent was obtained from the local ethical committee. Of these participants, 1437 were men (mean age 56.9 +/- 7.9 years) and 2071 were women (mean age 55.8 +/- 8.1 years). We measured GGT levels and various biochemical markers. To examine insulin resistance status, we used the homeostasis assessment method for insulin resistance (HOMA-IR). For inflammatory marker, we used C-reactive protein (CRP) levels. Results Serum GGT levels were significantly higher in the MS group compared to the healthy patient group [23 (5-1403) vs. 19 (5-1920) IU/l; P = 0.01]. The prevalence of MS and adjusted relative risk were both significantly increased from the lowest to highest GGT quartiles; these results persisted after adjustments for multiple confounders. Positive correlations were established between GGT and HOMA-IR or CRP. Conclusion These results suggest that GGT levels may be a surrogate marker of insulin resistance, inflammation and MS.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 38 条
  • [1] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [2] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [3] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [4] Associations between γ-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: A possible implication for oxidative stress
    Bo, Simona
    Gambino, Roberto
    Durazzo, Marilena
    Guidi, Sabrina
    Tiozzo, Elisa
    Ghione, Federica
    Gentile, Luigi
    Cassader, Maurizio
    Pagano, Gian Franco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (45) : 7109 - 7117
  • [5] γ-Glutamyltransferase and risk of stroke:: the EUROSTROKE project
    Bots, ML
    Salonen, JT
    Elwood, PC
    Nikitin, Y
    de Concalves, AF
    Inzitari, D
    Sivenius, J
    Trichopoulou, A
    Tuomilehto, J
    Koudstaal, PJ
    Grobbee, DE
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2002, 56 : I25 - I29
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] Insulin resistance, insulin response, and obesity as indicators of metabolic risk
    Ferrannini, Ele
    Balkau, Beverley
    Coppack, Simon W.
    Dekker, Jacqueline M.
    Mari, Andrea
    Nolan, John
    Walker, Mark
    Natali, Andrea
    Beck-Nielsen, Henning
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) : 2885 - 2892
  • [8] Ways of measuring drinking patterns and the difference they make: experience with graduated frequencies
    Greenfield, TK
    [J]. JOURNAL OF SUBSTANCE ABUSE, 2000, 12 (1-2) : 33 - 49
  • [9] Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
    Hotta, K
    Funahashi, T
    Bodkin, NL
    Ortmeyer, HK
    Arita, Y
    Hansen, BC
    Matsuzawa, Y
    [J]. DIABETES, 2001, 50 (05) : 1126 - 1133
  • [10] Association between elevated liver enzymes and C-reactive protein - Possible hepatic contribution to systemic inflammation in the metabolic syndrome
    Kerner, A
    Avizohar, O
    Sella, R
    Bartha, P
    Zinder, O
    Markiewicz, W
    Levy, Y
    Brook, GJ
    Aronson, D
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) : 193 - 197